Focus Partners Wealth Purchases 38,651 Shares of Haleon plc (NYSE:HLN)

Focus Partners Wealth increased its stake in shares of Haleon plc (NYSE:HLN - Free Report) by 132.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 67,928 shares of the company's stock after acquiring an additional 38,651 shares during the quarter. Focus Partners Wealth's holdings in Haleon were worth $686,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Fiduciary Trust Co boosted its position in shares of Haleon by 13.3% during the fourth quarter. Fiduciary Trust Co now owns 47,519 shares of the company's stock worth $453,000 after acquiring an additional 5,565 shares during the last quarter. Dimension Capital Management LLC boosted its position in shares of Haleon by 11.8% during the fourth quarter. Dimension Capital Management LLC now owns 16,010 shares of the company's stock worth $153,000 after acquiring an additional 1,689 shares during the last quarter. Eagle Global Advisors LLC bought a new position in shares of Haleon during the fourth quarter worth $2,137,000. Cubist Systematic Strategies LLC bought a new position in shares of Haleon during the fourth quarter worth $4,022,000. Finally, Cary Street Partners Financial LLC bought a new position in shares of Haleon during the fourth quarter worth $183,000. Institutional investors own 6.67% of the company's stock.

Analysts Set New Price Targets

A number of brokerages recently weighed in on HLN. HSBC restated a "hold" rating on shares of Haleon in a research report on Wednesday, March 5th. Barclays reiterated an "overweight" rating on shares of Haleon in a research report on Tuesday, May 6th. Morgan Stanley upgraded shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price objective for the company in a research report on Friday, May 9th. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating on shares of Haleon in a research report on Monday, March 3rd. Finally, Hsbc Global Res lowered shares of Haleon from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, March 5th. Five equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $11.25.

Haleon Trading Up 0.8%

Shares of HLN opened at $10.89 on Tuesday. Haleon plc has a twelve month low of $8.25 and a twelve month high of $10.90. The company has a market cap of $49.09 billion, a P/E ratio of 32.03, a P/E/G ratio of 2.82 and a beta of 0.24. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The company's fifty day simple moving average is $10.23 and its 200-day simple moving average is $9.87.

Haleon (NYSE:HLN - Get Free Report) last announced its earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. The business had revenue of $3.54 billion for the quarter, compared to the consensus estimate of $3.38 billion. As a group, analysts expect that Haleon plc will post 0.43 EPS for the current year.

Haleon Increases Dividend

The company also recently announced a -- dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 25th will be paid a $0.1166 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a dividend yield of 1.6%. This is an increase from Haleon's previous -- dividend of $0.05. Haleon's dividend payout ratio is currently 58.97%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon plc (NYSE:HLN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.